[HTML][HTML] Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies

Q Wang, X Qin, J Fang, X Sun - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Increasing understanding of the pathogenesis of rheumatoid arthritis (RA) has remarkably
promoted the development of effective therapeutic regimens of RA. Nevertheless, the …

[HTML][HTML] Topical nanocarriers for management of Rheumatoid Arthritis: A review

C Anita, M Munira, Q Mural, L Shaily - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Rheumatoid arthritis (RA) is a systemic autoimmune disease manifested by chronic joint
inflammation leading to severe disability and premature mortality. With a global prevalence …

Biomedical applications of polysaccharide nanoparticles for chronic inflammatory disorders: Focus on rheumatoid arthritis, diabetes and organ fibrosis

P Allawadhi, V Singh, K Govindaraj, I Khurana… - Carbohydrate …, 2022 - Elsevier
Polysaccharides are biopolymers distinguished by their complex secondary structures
executing various roles in microorganisms, plants, and animals. They are made up of long …

Significantly improving the bioefficacy for rheumatoid arthritis with supramolecular nanoformulations

C Ma, B Li, J Zhang, Y Sun, J Li, H Zhou… - Advanced …, 2021 - Wiley Online Library
As a typical inflammatory disease with chronic pain syndromes, rheumatoid arthritis (RA)
generally requires long‐term treatment with frequent injection administration at 1–2 times …

siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review

S Sargazi, R Arshad, R Ghamari… - Cell Biology …, 2022 - Wiley Online Library
Immune‐mediated diseases (IMDs) are chronic conditions that have an immune‐mediated
etiology. Clinically, these diseases appear to be unrelated, but pathogenic pathways have …

Emerging nanotherapeutics alleviating rheumatoid arthritis by readjusting the seeds and soils

W Zhang, Y Chen, Q Liu, M Zhou, K Wang… - Journal of Controlled …, 2022 - Elsevier
Rheumatoid arthritis (RA) is a complicated autoimmune disease that results in severe joint
inflammation, synovial hyperplasia, pannus formation, cartilage and bone destruction, and …

Nano-platform strategies of herbal components for the management of rheumatoid arthritis: a review on the battle for next-generation formulations

J Prabha, M Kumar, D Kumar, S Chopra… - Current Drug …, 2024 - ingentaconnect.com
Introduction: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that
initially affects small joints and then spreads to the bigger joints. It also affects other organs …

Nanomaterials for the diagnosis and treatment of inflammatory arthritis

SM Hosseinikhah, M Barani, A Rahdar… - International Journal of …, 2021 - mdpi.com
Nanomaterials have received increasing attention due to their unique chemical and physical
properties for the treatment of rheumatoid arthritis (RA), the most common complex …

Rheumatoid arthritis: Pathophysiology, current therapeutic strategies and recent advances in targeted drug delivery system

R Deshmukh - Materials Today Communications, 2023 - Elsevier
Recent advancements in technology and science thoroughly changed the basic
understanding and treatment approach of rheumatoid arthritis (RA). RA is a chronic …

Formulation of a dual drug-loaded nanoparticulate co-delivery hydrogel system and its validation in rheumatoid arthritis animal model

P Haloi, BS Lokesh, S Chawla, VB Konkimalla - Drug delivery, 2023 - Taylor & Francis
Rheumatoid arthritis (RA), a systemic autoimmune disease that dramatically affects patients'
quality of life. Given the intricacy of RA's pathophysiology, no single treatment can …